Chemours (CC) PT Lowered to $20 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Chemours (CC) Misses Q4 EPS by 1c ; Provides Outlook
February 18, 2025 6:03 AM ESTChemours (NYSE: CC) reported Q4 EPS of $0.11, $0.01 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.37 billion.
Full Year 2025 Outlook
The Company expects to deliver 2025 Adjusted EBITDA of $825 million... More
